Esperion Therapeutics reported $259.9M in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Amgen AMGN:US USD 37.35B 193M
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 1.17M
Cytokinetics CYTK:US USD 610.62M 888K
Daiichi Sankyo 4568:JP JPY 101.79B 94M
Esperion Therapeutics ESPR:US USD 259.9M 412K
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Heron Therapeutics HRTX:US USD 149.28M 50K
Intercept Pharmaceuticals ICPT:US USD 223.1M 248K
Moderna Inc MRNA:US USD 912M 10M
Ptc Therapeutics PTCT:US USD 1.28B 294.53M
Puma Biotechnology PBYI:US USD 98.31M 313K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
United Therapeutics UTHR:US USD 800M 0